Streetbeat News

Analyst Ratings

HOG

Baird analyst Craig Kennison has downgraded Harley-Davidson (NYSE:HOG) from Outperform to Neutral and reduced the price target from $44 to $40.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:16 am

SGMT

HC Wainwright & Co. analyst Ed Arce has reiterated a Buy rating for Sagimet Biosciences (NASDAQ:SGMT) and maintained a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:13 am

SEMR

Keybanc analyst Jason Ader maintains an Overweight rating on SEMrush Holdings (NYSE:SEMR) and raises the price target from $19 to $21.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:09 am

PCTY

Keybanc analyst Jason Celino maintains an Overweight rating on Paylocity Holding and raises the price target from $171 to $182.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:06 am

CARE

Hovde Group has initiated coverage on Carter Bankshares with an Outperform rating and set a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:02 am

HD

Gordon Haskett analyst Chuck Grom has upgraded Home Depot (NYSE:HD) from Accumulate to Buy, setting a price target of $450.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:55 am

ALUR

TD Cowen has initiated coverage on Allurion Technologies with a Buy rating and set a price target of $2. This suggests a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:52 am

PYPD

HC Wainwright & Co. has reiterated its Buy rating on PolyPid (NASDAQ:PYPD) and maintained a price target of $14, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:47 am

ADXN

HC Wainwright & Co. has reiterated its Buy rating on Addex Therapeutics (NASDAQ:ADXN) and maintained a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:39 am

KZR

HC Wainwright & Co. has downgraded Kezar Life Sciences from Buy to Neutral, which may impact investor sentiment and the stock's short-term performance.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 10:35 am